BUSI 528 Week 4 Product Strategy Paper Example

From Surgery Center to Weight Management Service Line: Changing a Bariatric Program's Strategy as GLP-1 Drugs Reshape Demand

Introduction

For a decade, a 300-bed hospital marketed its accredited bariatric surgery program with one message: surgery is the most effective treatment for severe obesity. Since GLP-1 medications such as semaglutide and tirzepatide became widely prescribed, the program's surgical referrals have fallen by about a fifth. Leaders first proposed more advertising. Berkowitz (2017) explains that products move through a life cycle of introduction, growth, maturity and decline, and that a product in decline usually needs a changed strategy, not louder promotion of the old one. The program's core product, surgery as a stand-alone service, has entered decline.

Why the Strategy Must Change

The decline is national. Wills et al. (2026) analyzed more than one million procedures in the national accreditation program database and found that volumes fell 23% from their 2022 peak, from 230,707 procedures to 177,789 in 2024, while conversion procedures, which revise an earlier operation, rose from 8.9% to 11.0% of cases and patients grew more medically complex. The medications are not a complete substitute, however. Huang et al. (2026) followed 201,229 adults with obesity but without diabetes who started GLP-1 drugs and found that only 30.7% were persistent users over twelve months, while 19.6% discontinued almost immediately and 23.5% stopped early. Many patients who start medication will stop, regain weight or need more than a drug can offer. That is the program's opportunity.

Components of the Strategy Change

Product. The program becomes a comprehensive weight management service line offering medical management with GLP-1 drugs, nutrition and exercise support, surgery for patients who need it and revision surgery for those whose earlier operations failed. This is a product line extension built on existing strengths: the surgeons, dietitians and psychologists already on staff know these patients, and the program's accreditation gives it credibility that a new medication clinic would lack.

Target segments. The program adds two segments: patients starting medication who want supervision and patients who have stopped medication and are regaining weight. The second group is the more urgent, since many stop because of side effects or cost and are left without a plan. A follow-up call to every patient who stops medication at a partner practice gives the program a natural point of contact.

Price. Medical management is billed through office visits and nutrition therapy, and the program negotiates a bundled rate with the largest employer plan for a year of comprehensive care.

Place. The program opens medical weight management clinics in two primary care offices, so patients meet the team before surgery is discussed, and it adds video follow-up visits for patients on medication who need monthly check-ins but live far from the hospital.

Promotion. The message changes from "surgery works" to "every option, one team," directed at primary care physicians, who now prescribe most GLP-1 drugs. Rather than competing with those physicians, the program offers to co-manage their patients, sharing notes and taking over when medication fails.

People. Surgeons, dietitians and a new obesity medicine physician train together so that every patient hears the full range of options.

Biblical Integration

Paul and his companions planned to preach in Asia and then Bithynia, but the Spirit did not allow them, and a vision called them to Macedonia instead; they concluded that God had called them there and went (English Standard Version Bible, 2001/2016, Acts 16:6-10). Faithful leaders hold their plans loosely enough to change course when the door closes, without abandoning the mission behind the plan. The program's mission, helping people with severe obesity live healthier lives, stays the same while its strategy changes, and staff should hear that message clearly.

Conclusion

After one year, leaders will measure enrolled patients in medical management, surgical volume including revisions and patient weight outcomes at six and twelve months.

References

Berkowitz, E. N. (2017). Essentials of health care marketing (4th ed.). Jones & Bartlett Learning.

English Standard Version Bible. (2016). Crossway. (Original work published 2001)

Huang, W., Kotecha, P., Kimmel, S. E., Segal, R., Gonzalvo, J. D., Pecoski, A. M., Wright, D., Bian, J., Smith, S. M., & Guo, J. (2026). Real-world adherence trajectories of GLP-1 receptor agonists among adults and paediatric patients with obesity. Diabetes, Obesity and Metabolism. Advance online publication. https://doi.org/10.1111/dom.71299

Wills, M. V., Zhu, X., Elamin, D., Corcelles, R., Kroh, M., Dang, J., Strong, A., Navarrete, S., & Mocanu, V. (2026). Declining bariatric surgery volumes and shifting practice patterns: A five-year analysis of over one million procedures. Obesity Surgery, 36(8), 4065-4074. https://doi.org/10.1007/s11695-026-08795-y